A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes

Clinical trial NCT03516591 · COMPLETED

Trial details

NCT number: NCT03516591
Sponsor: Amphivena Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2018-06-22
Primary completion: 2020-07-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.